HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Experimental gonarthrosis in rats and its therapy with glycosaminoglycan polysulfate (GAGPS)].

Abstract
In good correlation to earlier results in hens we found that after intraarticular injections of iodo-acetate into the knee joint of rats, degenerative alterations of the articular cartilage and subchondral bone tissue develop within 2-4 months. The radiological, histological and macroscopical appearance of these degenerative processes in rats is quite similar to those in human osteoarthrosis (OA). Drug treatment of these rats with twice weekly subcutaneous doses of 1.0 mg, 2.0 mg or 5.0 mg glycosaminoglycan polysulphate = GAGPS (Arteparon) per kg body weight caused a pronounced and in many cases highly significant reduction of the intensity of experimental osteoarthrosis within the first 9 weeks. Due to the very severe acceleration of OA (induced by the high dose of 1.0 mg iodo-acetate) GAGPS could not influence the further progression of cartilage degeneration and destruction during the period of 12-15 weeks. The present results on rats confirm our preceding studies with biochemically induced OA in hens and demonstrate the identical reactions of both animal species to induction and therapy of degenerative joint disease.
AuthorsU Buchmann, D A Kalbhen
JournalZeitschrift fur Rheumatologie (Z Rheumatol) 1985 May-Jun Vol. 44 Issue 3 Pg. 100-7 ISSN: 0340-1855 [Print] Germany
Vernacular TitleDie tierexperimentelle Gonarthrose der Ratte und ihre Therapie mit Glykosaminoglykanpolysulfat (GAGPS).
PMID4060902 (Publication Type: Journal Article)
Chemical References
  • Glycosaminoglycans
  • A73025
Topics
  • Animals
  • Glycosaminoglycans (therapeutic use)
  • Knee Joint
  • Male
  • Osteoarthritis (drug therapy, pathology)
  • Rats
  • Rats, Inbred Strains

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: